期刊
CANCER CELL
卷 28, 期 2, 页码 145-147出版社
CELL PRESS
DOI: 10.1016/j.ccell.2015.07.008
关键词
-
资金
- NIDDK NIH HHS [K99 DK103126] Funding Source: Medline
In this issue of Cancer Cell, Herrero and colleagues identify an anti-tumorigenic small molecule that blocks ERK dimerization, but neither its catalytic activity nor its phosphorylation by MEK. These findings demonstrate that targeting protein dimerization could be a therapeutic avenue for inhibiting kinase signaling pathways associated with lower drug resistance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据